Menopausal symptoms. Menopausal and other perimenopausal disorders
Conditions
Interventions
Intervention 1: Intervention group: Recipient of gelatin capsules containing 80 mg of lavender essential oil. The course of drug consumption is 60 days and one capsule is consumed daily after a meal,
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Be literate enough to fill out a questionnaire or presence of a literate person in the family Having a normal menopause Women who were menopause less than 6 years ago Having a minimum of 45 and a maximum of 60 years of age Earning a minimum score of 15 and a maximum of 42 in the Green assessment
Exclusion criteria
Exclusion criteria: Use of tobacco and alcoholic beverages and herbal medicines Existence of stressors such as the death of first-degree relatives in the last 6 months and job loss Existence of malignant disease Recent history of surgery and trauma Lavender consumption during the 3 months before the study Use of hormone therapy during the past 6 months Having known physical and mental illnesses according to self-expression (depression, uncontrolled diabetes, cardiovascular diseases)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Green scale symptoms score in postmenopausal women. Timepoint: Before and after intervention. Method of measurement: Green questionnaire.;Serum cortisol levels. Timepoint: Before and after intervention. Method of measurement: Enzyme-linked immunosorbent assay (ELISA) method by ELISA kits. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reported possible side effects. Timepoint: After the intervention. Method of measurement: Checklist of possible side effects.;The level of satisfaction with the intervention received. Timepoint: After the intervention. Method of measurement: Satisfaction checklist received from the intervention.;Serum levels of lipid profile. Timepoint: Before and after intervention. Method of measurement: By spectrophotometric method with device with Alcyon 300 model and Pars test kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Azizeh Farshbaf-Khalili
Tabriz University of Medical Sciences
Outcome results
None listed